Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

ChemoCentryx begins phase I trial of CCX-832 under alliance with GSK

Jan. 27, 2011

Kyowa Hakko Kirin and Amgen collaborate on AMG-827

Jan. 27, 2011

GenVec and U.S. NMRC collaborate on vaccine for dengue fever

Jan. 26, 2011

Theraclone and Pfizer to codevelop antibodies against infectious disease and cancer targets

Jan. 21, 2011

Evotec and Takeda Cambridge join to identify GPCR and protease modulators

Jan. 21, 2011

Harbor BioSciences licenses three compounds to CIPI in China

Jan. 20, 2011

PROLOR and Yeda sign agreement for reversible PEGylation technology

Jan. 20, 2011

Johns Hopkins Brain Science Institute and Ortho-McNeil-Janssen enter collaboration

Jan. 20, 2011

Ironwood Pharma and Protagonist Therapeutics join to develop new peptide therapeutics

Jan. 20, 2011

Chugai grants Circadian Technologies global license to VEGF-D program

Jan. 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...